Page 2 - Ith 100 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pune (Maharashtra) [India]/ Bellevue (Washington) [US], April 28 (ANI/PRNewswire): Icertis today announced that artificial intelligence (AI) was applied to nearly 50 per cent more contracts on its platform in 2022 compared to the previous year. This affirms continued momentum behind AI adoption in contract-driven processes as forward-looking enterprises seek to transform operations, inform strategic decision-making, and realize the full intent of their commercial agreements with contract intelligence. Contract Intelligence Pioneer Innovates with AI to Unlock Strategic Value for Customers. Cont...

Bellevue (Washington) [US]/ Pune (Maharashtra) [India], April 6 (ANI/PRNewswire): Icertis, the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM), today announced it was named a winner in the 2023 Artificial Intelligence Excellence Awards program led by the Business Intelligence Group. Icertis was selected for its ability to harness the power of AI and contract data to deliver the only contract intelligence solution built to meet the complex needs of the enterprise. This honor is a testament to the company's innovation a...

Investors Are Wondering How to Navigate This Bear Market MELBOURNE, Australia, Nov. 7, 2022 /PRNewswire/ -- Financial publisher Fat Tail Investment Research's latest research guide on surviving bear markets and recessions argues that investors have room to manoeuvre, provided they understand historical precedents. Investors Are Wondering How to Navigate This Bear Market Fat Tail's investment guide notes that the recent difficulty navigating markets is exacerbated by the fragility of global economies rocked by rampant inflation. Investors have spent much of 2022 wondering how to protect...

Petros Pharmaceuticals, Inc. announces today they will be pursuing the 505(b)(2) pathway for its investigational agent, H-100™, a novel, patented, non-invasive topical treatment being developed for Peyronie’s disease, a condition impacting more than 1 in 10 men in the US.

Company Is Developing H-100 as Potentially the First FDA-Approved, Nanoparticle-Based Topical Treatment Designed to Provide Improved and Sustained Local...